Imperatorin as a Promising Chemotherapeutic Agent against Human Larynx Cancer and Rhabdomyosarcoma Cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Imperatorin as a Promising Chemotherapeutic Agent against Human Larynx Cancer and Rhabdomyosarcoma Cells
Authors
Keywords
-
Journal
MOLECULES
Volume 25, Issue 9, Pages 2046
Publisher
MDPI AG
Online
2020-04-29
DOI
10.3390/molecules25092046
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Progress in research on paclitaxel and tumor immunotherapy
- (2019) Linyan Zhu et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Autophagy inhibition enhances Matrine derivative MASM induced apoptosis in cancer cells via a mechanism involving reactive oxygen species-mediated PI3K/Akt/mTOR and Erk/p38 signaling
- (2019) Yuming Zou et al. BMC CANCER
- Activating PXR by Imperatorin Attenuates Dextran Sulphate Sodium-Induced Colitis in Mice
- (2018) Meijing Liu et al. BRITISH JOURNAL OF PHARMACOLOGY
- 8-methoxypsoralen reduces AKT phosphorylation, induces intrinsic and extrinsic apoptotic pathways, and suppresses cell growth of SK-N-AS neuroblastoma and SW620 metastatic colon cancer cells
- (2017) Magdalena Bartnik et al. JOURNAL OF ETHNOPHARMACOLOGY
- Imperatorin efficiently blocks TNF-α-mediated activation of ROS/PI3K/Akt/NF-κB pathway
- (2017) Ke Si Wang et al. ONCOLOGY REPORTS
- Effects of Psoralen as an Anti-tumor Agent in Human Breast Cancer MCF-7/ADR Cells
- (2016) Xiaohong Wang et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Screening of promising chemotherapeutic candidates from plants extracts
- (2016) Junei Kinjo et al. Journal of Natural Medicines
- Screening of promising chemotherapeutic candidates from plants against human adult T-cell leukemia/lymphoma (V): coumarins and alkaloids from Boenninghausenia japonica and Ruta graveolens
- (2016) Daisuke Nakano et al. Journal of Natural Medicines
- Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment
- (2016) Shanthi Marur et al. MAYO CLINIC PROCEEDINGS
- Imperatorin exhibits anticancer activities in human colon cancer cells via the caspase cascade
- (2016) YI MEI ZHENG et al. ONCOLOGY REPORTS
- Imperatorin–pharmacological meaning and analytical clues: profound investigation
- (2016) Ewelina Kozioł et al. PHYTOCHEMISTRY REVIEWS
- Simultaneous determination and pharmacokinetics of sixteen Angelicae dahurica coumarins in vivo by LC–ESI-MS/MS following oral delivery in rats
- (2016) Ai-Hong Zhao et al. PHYTOMEDICINE
- A Review on Chemical Profile of Coumarins and their Therapeutic Role in the Treatment of Cancer
- (2016) K. Venkata Sairam et al. Current Drug Delivery
- Investigation of the mechanisms of Angelica dahurica root extract-induced vasorelaxation in isolated rat aortic rings
- (2015) Kyungjin Lee et al. BMC Complementary and Alternative Medicine
- 8-Methoxypsoralen Induces Intrinsic Apoptosis in HepG2 Cells: Involvement of Reactive Oxygen Species Generation and ERK1/2 Pathway Inhibition
- (2015) Huan Yang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Separation and simultaneous quantification of nine furanocoumarins fromRadix Angelicae dahuricaeusing liquid chromatography with tandem mass spectrometry for bioavailability determination in rats
- (2015) Lin Chen et al. JOURNAL OF SEPARATION SCIENCE
- Imperatorin acts as a cisplatin sensitizer via downregulating Mcl-1 expression in HCC chemotherapy
- (2015) Jianjian Hu et al. TUMOR BIOLOGY
- Bergamottin, a natural furanocoumarin obtained from grapefruit juice induces chemosensitization and apoptosis through the inhibition of STAT3 signaling pathway in tumor cells
- (2014) Sung-Moo Kim et al. CANCER LETTERS
- Combined treatment with quercetin and imperatorin as a potent strategy for killing HeLa and Hep-2 cells
- (2014) Dorota Bądziul et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Anticonvulsant effects of four linear furanocoumarins, bergapten, imperatorin, oxypeucedanin, and xanthotoxin, in the mouse maximal electroshock-induced seizure model: a comparative study
- (2014) Jarogniew J. Łuszczki et al. Pharmacological Reports
- Counter-current chromatography for the separation of terpenoids: a comprehensive review with respect to the solvent systems employed
- (2014) Krystyna Skalicka-Woźniak et al. PHYTOCHEMISTRY REVIEWS
- Psoralen reverses docetaxel-induced multidrug resistance in A549/D16 human lung cancer cells lines
- (2014) Ming-Ju Hsieh et al. PHYTOMEDICINE
- PreliminaryIn VitroandIn VivoEvaluation of Antidiabetic Activity ofDucrosia anethifoliaBoiss. and Its Linear Furanocoumarins
- (2014) Nagwa M. M. Shalaby et al. Biomed Research International
- Simultaneous determination of imperatorin and its metabolitesin vitroandin vivoby a GC-MS method: application to a bioavailability and protein binding ability study in rat plasma
- (2013) Gang Zhao et al. BIOMEDICAL CHROMATOGRAPHY
- Simultaneous determination of imperatorin and its metabolite xanthotoxol in rat plasma by using HPLC–ESI-MS coupled with hollow fiber liquid phase microextraction
- (2013) Juan Zhang et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Effects of imperatorin on nicotine-induced anxiety- and memory-related responses and oxidative stress in mice
- (2013) Barbara Budzynska et al. PHYSIOLOGY & BEHAVIOR
- Human Rhabdomyosarcoma Cell Lines for Rhabdomyosarcoma Research: Utility and Pitfalls
- (2013) Ashley R. P. Hinson et al. Frontiers in Oncology
- Evaluation of phototoxic potential of aerial components of the fig tree against human melanoma
- (2012) F. Conforti et al. CELL PROLIFERATION
- Evidence that Bergapten, Independently of its Photoactivation, Enhances p53 Gene Expression and Induces Apoptosis in Human Breast Cancer Cells
- (2009) M. Panno et al. CURRENT CANCER DRUG TARGETS
- A Review of Coumarin Derivatives in Pharmacotherapy of Breast Cancer
- (2008) Musiliyu Musa et al. CURRENT MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started